Reinfection of COVID-19 with multisystem manifestations in a medical worker: clinical observation

The new SARS-CoV-2 coronavirus and the COVID-19 disease caused by it in medical workers can be considered as an occupational disease if the infection occurred while they were performing their official duties.

Along with damage to the respiratory system, SARS-CoV-2 can lead to hematological disorders, disorders of the nervous system, the development of autoimmune and rheumatic diseases.

The presented clinical case describes possible serious multisystem pathological manifestations associated with a new coronavirus infection — pulmonary fibrosis, polyneuropathy.

We have described the reinvention of SARS-CoV-2 with subsequent hematological disorders, complications from the musculoskeletal system in the form of aseptic osteonecrosis of the femoral heads.

The scientists have presented the principles and results of the medical examination conducted in order to establish a causal relationship of the disease with the professional activity of a medical worker.

We emphasize the need for a multidisciplinary approach to the diagnosis of manifestations, treatment of COVID-19 and its complications with the mandatory participation of a neurologist and rheumatologist.

Contribution:
Strizhakov L.A. — the concept and design of the study;
Babanov S.A. — the concept and design of the study, text writing;
Gulyaev S.V. — text writing, editing;
Azovskova T.A. — the concept and design of the study, data collection and processing, text writing;
Lavrentieva N.E. — text writing, editing;
Baraeva R.A. — data collection and processing, editing.

Funding. The study had no funding.

Conflict of interests. The authors declare no conflict of interests.

Received: 22.10.2022 / Accepted: 24.10.2022 / Published: 25.11.2022

1. Bukhtiyarov I.V. Epidemiological and clinical-expert problems of occupational infectious morbidity of workers in the provision of medical care in the context of the COVID-19 pandemic. Med. truda i prom ekol. 2021; 61(1): 4–12.

2. Kosarev. V.V., Babanov S.A. Occupational diseases of medical workers. Samara: LLC "Ofort"; 2014.

3. New coronavirus infection COVID-19: professional aspects of maintaining the health and safety of medical workers: guidelines. Ed. I.V. Bukhtiyarov, Yu.Yu. Gorblyansky. 2nd ed., revised. and additional M.: AMT, FGBNU NII MT, 2022.

4. Garipova R.V., Strizhakov L.A., Gorblyansky Yu.Yu., Babanov S.A. New coronavirus infection as an occupational disease: complex expert cases. Med. truda i prom ekol. 2021; 61(11): 720–25.

5. Interim guidelines "Prevention, diagnosis and treatment of a new coronavirus infection (COVID-19)". Version 15 (02/22/2022).

6. Li J., Gao J., Xu Y.P. et al. Expression of severe acute respiratory syndrome coronavirus receptors, ACE2 and CD209L in different organ derived microvascular endothelial cells. Zhonghua Yi Xue Za Zhi. 2007; 87(12): 833–7.

7. Song W.-C., FitzGerald G.A. COVID-19, microangiopathy, hemostatic activation, and complement. J Clin Invest. 2020; 130(8): 3950–53.

8. Vabret N., Britton G.J., Gruber C., et al. Immunology of COVID-19: Current state of the science. Immunity. 2020; 52(6): 910–41.

9. Nasonov E.L., Beketova T.V., Reshetnyak T.M. Coronavirus disease 2019 (COVID-19) and immunoinflammatory rheumatic diseases: at the crossroads of thrombo-inflammation and autoimmunity. Nauchno-prakticheskaya revmatologiya. 2020; 58(4): 353–67.

10. Weatherhead J.E., Clark E., Vogel T.P., et al. Inflammatory syndromes associated with SARS-CoV-2 infection: dysregulation of the immune response across the age spectrum. J Clin Invest. 2020; 130(12): 6194–7.

11. Pascolini S., Vannini A., Deleonardi G., et al. COVID-19 and Immunological Dysregulation: Can Autoantibodies be Useful? Clin Transl Sci. 2021; 14(2): 502–8. https://doi.org/10.1111/cts.12908

12. Ludwig R.J., Vanhoorelbeke K., Leypoldt F., et al. Mechanisms of autoantibodyinduced pathology. Front Immunol. 2017; 8: 603.

13. Gusev E.I., Martynov M.Yu., Boyko A.N. et al. Novel coronavirus infection (COVID-19) and nervous system involvement: pathogenesis, clinical manifestations, organization of neurological care. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2020; 120(6): 7–16. (In Russian).

14. Baig A.M., Khaleeq A., Ali U. et al. Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host virus interaction, and proposed neurotropic mechanisms. ACS Chem Neurosci. 2020; 11(7): 995–8.

15. Kamchatnov P.R., Evzelman M.A., Chugunov A.V. Damage to the peripheral nervous system in COVID-19 coronavirus infection. Russky meditsinsky zhurnal. 2021; (5): 30–4.

16. Zhou L., Zhang M., Wang J., et al. Sars-CoV-2: Underestimated damage to nervous system (published online ahead of print, 2020 Mar 24). Travel Med Infect Dis. 2020; 101642.

17. Mao L., Jin H., Wang M. et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China (published online ahead of print, 2020 Apr 10]). JAMA Neurol. 2020; 77(6): 1–9.

18. Wang L., Shen Y., Li M. et al. Clinical manifestations and evidence of neurological involvement in 2019 novel coronavirus SARS-CoV-2: a systematic review and meta-analysis. J. Neurol. 2020; (10): 2777–89.

19. Patersen R.W., Brown R.L., Benjamin L. et al. The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings. Brain. 2020; (8): awaa2402020.

20. Benussi A., Pilotto A., Premi E. et al. Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy [published online ahead of print, 2020 May 22]. Neurology. 2020; https://doi.org/10.1212/WNL.0000000000009848

21. Ternovykh I.K., Topuzova M.P., Chaikovskaya A.D. Neurological manifestations and complications in patients with COVID-19. Translyatsionnaya meditsina. 2020; 7(3): 21–9.

22. Ciaffi J., Meliconi R., Ruscitti P. et al. Rheumatic manifestations of COVID-19: a systematic review and meta-analysis. BMC Rheumatol. 2020; 4: 65.

23. Nasonov E.L. Coronavirus disease 2019 (COVID-19): reflections from a rheumatologist. Nauchno-prakticheskaya revmatologiya. 2020; 58(2): 123–32.

24. Panin M.A., Petrosyan A.S., Khadzhiharalambus K.Kh., Boyko A.V. Osteonecrosis of the femoral head after COVID-19: a case series. Travmatologiya i ortopediya Rossii. 2022; 28(1): 110–17. https://doi.org/10.17816/2311-2905-1687

25. Agarwala S.R., Vijayvargiya M., Pandey P. Avascular necrosis as a part of ‘long COVID-19’. BMJ Case Rep. 2021; 14(7): e242101. https://doi.org/10.1136/bcr-2021-242101

26. Wang A., Ren M., Wang J. The pathogenesis of steroidinduced osteonecrosis of the femoral head: A systematic review of the literature. Gene. 2018; 671: 103–109. https://doi.org/10.1016/j.gene.2018.05.091

27. Mont M.A., Pivec R., Banerjee S., Issa K., Elmallah R.K., Jones L.C. High-Dose Corticosteroid Use and Risk of Hip Osteonecrosis: Meta-Analysis and Systematic Literature Review. J Arthroplasty. 2015; 30(9): 1506–1512.e5. https://doi.org/10.101.6/j.arth.2015.03.036